Ventas (NYSE:VTR) Price Target Raised to $93.00 at Wells Fargo & Company

Ventas (NYSE:VTR) had its price target lifted by Wells Fargo & Company from $88.00 to $93.00 in a research report sent to investors on Thursday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the real estate investment trust’s stock.

VTR has been the topic of a number of other reports. Argus set a $88.00 price target on shares of Ventas in a research report on Tuesday, February 10th. Royal Bank Of Canada boosted their price objective on shares of Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research report on Tuesday, February 10th. Mizuho increased their price objective on shares of Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Morgan Stanley set a $90.00 target price on shares of Ventas in a report on Friday, February 13th. Finally, Citigroup lifted their target price on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Ventas has an average rating of “Moderate Buy” and an average target price of $90.47.

Ventas Stock Performance

VTR stock opened at $82.52 on Thursday. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.03. The firm has a market cap of $39.19 billion, a P/E ratio of 152.81, a P/E/G ratio of 2.04 and a beta of 0.73. Ventas has a 12-month low of $60.15 and a 12-month high of $88.36. The stock’s 50 day simple moving average is $82.97 and its 200 day simple moving average is $77.37.

Ventas (NYSE:VTR) last announced its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The firm had revenue of ($1,229.71) million for the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter last year, the business earned $0.81 earnings per share. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities research analysts predict that Ventas will post 3.4 EPS for the current year.

Ventas Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, March 31st. Ventas’s payout ratio is currently 355.56%.

Insider Buying and Selling

In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the sale, the chief executive officer owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president owned 72,755 shares in the company, valued at approximately $6,184,175. This represents a 32.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 86,106 shares of company stock valued at $6,931,397 in the last quarter. Company insiders own 0.80% of the company’s stock.

Institutional Investors Weigh In On Ventas

A number of hedge funds have recently made changes to their positions in VTR. NewEdge Advisors LLC increased its position in Ventas by 856.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after acquiring an additional 7,097 shares during the period. Empowered Funds LLC boosted its position in Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after acquiring an additional 536 shares during the period. Woodline Partners LP boosted its position in Ventas by 46.8% during the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after acquiring an additional 11,739 shares during the period. Focus Partners Wealth grew its stake in shares of Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after purchasing an additional 12,233 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in shares of Ventas by 3.4% during the second quarter. Cetera Investment Advisers now owns 36,918 shares of the real estate investment trust’s stock valued at $2,331,000 after purchasing an additional 1,209 shares during the period. Institutional investors own 94.18% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.